twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2019
vol. 121
 
Share:
Share:
abstract:
Case report

Rheumatoid arthritis-associated uveitis treated with adalimumab

Elżbieta Kalaczyńska
1
,
Ewa Bilińska
1
,
Marta Owidzka
1
,
Wojciech Omulecki
1

  1. Department of Ophthalmology, Medical University of Lodz, Poland Head: Professor Wojciech Omulecki, MD, PhD
Online publish date: 2019/09/23
View full text Get citation
 
PlumX metrics:
Uveitis is an inflammatory ocular disorder of various aetiology affecting the middle vascular layer of the eye. The condition mainly affects relatively young patients and if untreated, it can lead to significant complications, including blindness. Hence, it is of a critical importance to prevent inflammation and vision loss in eyes with uveitis.

Here, we report a case of a 36-year-old male with a history of rheumatoid arthritis, who was first diagnosed with anterior uveitis, and subsequently presented with macular oedema and epiretinal membranes. However, conventional treatment with a steroid was not sufficient to control the inflammation and was associated with elevated intraocular pressure as a side effect. Eventually, the patient was treated with adalimumab, which effectively prevented disease progression and resolved his rheumatoid symptoms.
keywords:

uveitis, adalimumab, rheumatoid arthritis, macular oedema, epiretinal membrane

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.